Florida Blue, a leading health insurer in Florida, and artificial intelligence (AI) developer Olive today announced a collaboration to become the first U.S. payer to automate insurer authorization approvals through AI-powered clinical reviews, resulting in faster care for patients and greater provider satisfaction. According to Guidewell, the parent company of Florida Blue, the partnership will transform a frustrating, labor-intensive process, resulting in faster care for patients and improved provider satisfaction.
By deploying Olive’s AI platform, prior authorization decision-making translates to the point of care, like a doctor’s office or clinic. The solution will enable members to receive authorizations, the approval from the health plan before you get a service or fill a prescription, faster by giving providers immediate approval from GuideWell (sometimes before a member leaves their provider’s office) when Olive’s artificial intelligence determines the prior authorization request meets GuideWell’s medical necessity requirements.
“Olive’s AI platform helps GuideWell create a best-in-class utilization management model that reduces the administrative burden on our providers while creating a better experience for our members,” said Dr. Elana Schrader, Florida Blue Senior Vice President. “By being the first health plan to automate approvals, we are leading the way for insurers to close the technology gap to better serve our members and providers.”
CONTINUE READING AT: THE CAPITOLIST